Mitochondria as a Therapeutic Target in Heart Failure
- 12 February 2013
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 61 (6), 599-610
- https://doi.org/10.1016/j.jacc.2012.08.1021
Abstract
No abstract availableFunding Information
- National Institutes of Health (K02 HL107448, R01 HL104181, 1P01 HL108795)
This publication has 144 references indexed in Scilit:
- AMPK isoform expression in the normal and failing heartsJournal of Molecular and Cellular Cardiology, 2012
- Lack of the Mitochondrial Protein Acylglycerol Kinase Causes Sengers SyndromeAmerican Journal of Human Genetics, 2012
- Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failureJournal of Molecular and Cellular Cardiology, 2011
- Targeting AMPK for cardiac protection: Opportunities and challengesJournal of Molecular and Cellular Cardiology, 2011
- The heart in Friedreich's Ataxia: Basic findings and clinical implicationsProgress in Pediatric Cardiology, 2011
- Mitochondrial Fission and Autophagy in the Normal and Diseased HeartCurrent Hypertension Reports, 2010
- Regulation of mitochondrial processes: A target for heart failureDrug Discovery Today: Disease Mechanisms, 2010
- Doxorubicin Inactivates Myocardial Cytochrome c Oxidase in Rats: Cardioprotection by Mito-QBiophysical Journal, 2009
- Sex-specific pathways in early cardiac response to pressure overload in miceJournal of Molecular Medicine, 2008
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004